Stigma, risks, and benefits of medicinal cannabis use among Australians with cancer

Author:

Morris Julia N1,Loyer Jessica2,Blunt Jason3

Affiliation:

1. Cancer Council SA

2. William Angliss Institute

3. PsychMed SA

Abstract

Abstract Purpose People with cancer who use medicinal cannabis do so despite risks associated with limited clinical evidence, legalities, and stigma. This study investigated how Australians with cancer rationalise their medicinal cannabis use despite its risks. Methods Ten adults who used cannabis medicinally for their cancer were interviewed about how they used and accessed the substance, attitudes and beliefs underpinning their use, and conversations with others about medicinal cannabis. Results Participants used cannabis to treat a variety of cancer-related symptoms such as pain, poor sleep, and low mood. Cannabis was perceived as natural and thus less risky than pharmaceuticals. Participants legitimised their medicinal cannabis use by emphasising its natural qualities and distancing themselves from problematic users or riskier substances. Cost barriers and a lack of healthcare professional communication impeded prescription access. Similarly, participants navigated medicinal cannabis use independently due to a lack of guidance from healthcare professionals. Conclusion Findings highlight the need for robust data regarding the harms and efficacy of medicinal cannabis that healthcare professionals can disseminate to patients who choose to use the substance. Ensuring healthcare professionals are equipped to provide non-judgmental and evidence-based guidance may mitigate potential safety and legal risks.

Publisher

Research Square Platform LLC

Reference38 articles.

1. ‘The therapeutic potential of cannabis and cannabinoids’;Grotenhermen F;Dtsch. Ärztebl. Int.,2012

2. ‘Efficacy and adverse effects of medical marijuana for chronic noncancer pain’;Deshpande A;Can. Fam. Physician,2015

3. ‘Does cannabindiol have a benefit as a supportive care drug in cancer?’;Lord S;Curr. Treat. Options Oncol.,2022

4. Australian Institute of Health and Welfare, ‘Emerging topic: Medicinal cannabis (National Drug Strategy Household Survey 2019)’, 2020. https://www.aihw.gov.au/getmedia/108d1761-b523-492b-81cc-a09db6740e85/aihw-phe-270-Chapter6-Medicinal-cannabis.pdf.aspx

5. ‘Prevalence and correlates of cannabis use for medicinal reasons - An Australian cross-sectional study’;Leung J;Addict. Behav. Rep.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3